ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 102 filers reported holding ENZO BIOCHEM INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $5,000 | -72.2% | 1,315 | -81.0% | 0.00% | – |
Q4 2020 | $18,000 | +350.0% | 6,932 | +236.0% | 0.00% | – |
Q3 2020 | $4,000 | -90.7% | 2,063 | -87.1% | 0.00% | – |
Q2 2020 | $43,000 | +38.7% | 15,972 | +17.2% | 0.00% | – |
Q1 2020 | $31,000 | +106.7% | 13,627 | +138.1% | 0.00% | – |
Q4 2019 | $15,000 | +7.1% | 5,723 | +47.8% | 0.00% | – |
Q3 2019 | $14,000 | +7.7% | 3,871 | +3.5% | 0.00% | – |
Q2 2019 | $13,000 | +550.0% | 3,739 | +502.1% | 0.00% | – |
Q4 2018 | $2,000 | +100.0% | 621 | +104.3% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 304 | -2.9% | 0.00% | – |
Q2 2018 | $2,000 | -98.1% | 313 | -97.5% | 0.00% | – |
Q4 2017 | $104,000 | -22.4% | 12,738 | 0.0% | 0.00% | – |
Q3 2017 | $134,000 | -32.3% | 12,738 | -28.8% | 0.00% | – |
Q2 2017 | $198,000 | +32.0% | 17,890 | 0.0% | 0.00% | – |
Q1 2017 | $150,000 | +23.0% | 17,890 | 0.0% | 0.00% | – |
Q4 2016 | $122,000 | +2340.0% | 17,890 | +633.2% | 0.00% | – |
Q2 2013 | $5,000 | – | 2,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |